Tag Archive for: FDA
Coronavirus and Cancer Resources for Survivors
Cancer survivors have expressed concerns and questions about COVID-19, the coronavirus, and how they may be at higher risk due to their cancer history. Here are some resources about COVID-19 generally, and its impact for cancer survivors specifically. NCCS is seeking answers from public health experts on the coronavirus and its impact on cancer patients and survivors. Please leave a comment [...]
NCCS Statement on the Passage of the STAR Childhood Cancer Act and the Right to Try Act
Silver Spring, MD – The National Coalition for Cancer Survivorship issued the following statement regarding passage of both the…
NCCS Joins Cancer Leadership Council to Oppose Right to Try Legislation in the House
The National Coalition for Cancer Survivorship joined with other organizations of the Cancer Leadership Council (CLC) in a letter to…
What Caught Our Eye: ACA Auto-Enrollment; Lack of Care Plan Implementation; Second Opinions; ‘Cancer’s New Superheroes’; More
What Caught Our Eye (WCOE) is our week-in-review blog series. “Making Heath Insurance Enrollment As Automatic As Possible” — Via Health Affairs Blog — In December 2017, the Republican Congress, working with the Trump administration, repealed the tax penalties enforcing the Affordable Care Act’s (ACA) individual mandate, effective in 2019. Although the degree of the mandate’s efficacy is uncertain, its repeal is sure to lead to additional Americans [...]
WCOE: Health Care Access and Affordability; FDA’s Plans to Better Incorporate Patient Voice in Drug Development; Patient Portal Pitfalls; and More
What Caught Our Eye (WCOE) is our week-in-review blog series, where we recap the cancer policy articles, studies, and stories that caught our attention. — “Why Some Americans Are Risking It and Skipping Health Insurance” — In tiny Marion, North Carolina, the Buchanans decided that $1,800 a month was too much to pay for health insurance, and are going without it for the first time in their lives. [...]
WCOE: HHS Hints at Lax ACA Regulation; Burden of High Drug Costs; FDA’s Gottlieb Blasts ‘Rigged Payment Scheme’; Home BRCA Testing; More
What Caught Our Eye is our week-in-review blog series, where we recap the cancer policy articles, studies, and stories that caught our attention. – “Trump Administration Blocks Idaho’s Plan to Circumvent Health Law” –
While rejecting Idaho’s plan in its current form, Ms. Verma encouraged the state to keep trying, and she suggested that, “with certain modifications,” its proposal might be accepted. [...]
NCCS Joins Letter Expressing “Serious Reservations” About “Right to Try” Legislation
NCCS joined with colleagues in the Cancer Leadership Council to express serious reservations about proposed “right to try” legislation…
What Caught Our Eye: NCI Chief Sharpless Interviewed; Expert Patients; “Why We Didn’t Seek Right to Try”; Progress in Survivorship Care; and More
What Caught Our Eye is our week-in-review blog series, where we recap the cancer policy articles, studies, and stories that caught our attention. – Health Insurance – “Bait And Switch: The Sneaky Way Your Employer Just Passed Healthcare Costs Onto You” By Peter Ubel, Forbes.com — With increasing frequency, employers are directing their workers to the kind of high deductible, high out-of-pocket insurance plans that leave workers financially responsible [...]
What Caught Our Eye: How the Senate Tax Bill Affects Health Care, Surgical Relief for Lymphedema, and An Investigation Into Exorbitant Costs of Care
What Caught Our Eye is our week-in-review blog series, where we recap the cancer policy articles, studies, and stories that caught our attention. “JCT says Republican tax plan will add $1 trillion to the deficit” — There is no consensus among economists about the amount of growth that would occur under the plan, but key models predict it would not cover its cost. Find out more about the implications of the tax bill. [...]
What Caught Our Eye: ACA Individual Mandate Explainer, Medicaid Work Requirements, Metastatic Breast Cancer Research, and More
What Caught Our Eye (WCOE), November 17, 2017 — “Obamacare’s individual mandate, the new target in the GOP tax plan, explained” | The revised Senate tax bill would repeal the individual mandate. Repealing the mandate — which is the gear that makes the Affordable Care Act tick — would save more than $300 billion over 10 years, but only because millions fewer Americans would have health insurance, according to the Congressional [...]
WCOE: Bipartisan Health Care Deal Details; Fertility Banks Underused by Young Male Survivors; Cancer Stress; High Drug Pricing; and More
What Caught Our Eye is our week-in-review blog series, where we recap the cancer policy articles, studies, and stories that caught our attention. “The Senate’s new Obamacare stabilization deal, explained” – By Dylan Scott, Vox.com — We have an Obamacare stabilization deal. Republican Sen. Lamar Alexander, who had been working with Democratic Sen. Patty Murray for the past few months, announced it this afternoon. This would be [...]